tumor-specific antigen,TSA 是什么意思，中文意思 | 肿瘤特异性抗原英文怎么说医学英语中英文词汇翻译

Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation

S Sreeja, TR Santhosh Kumar, BS Lakshmi… - The Journal of …, 2011 - Elsevier
Selective estrogen receptor modulators (SERMs) are estrogen receptor (ER) ligands exhibiting
tissue-specific agonistic or antagonistic biocharacter and are used in the hormonal therapy for
estrogen-dependent breast cancers. Pomegranate fruit has been shown to exert ...

Vasculogenensis, angiogenesis and special features of tumor blood vessels.

S Hiratsuka - Frontiers in bioscience: a journal and virtual library, 2011 - ncbi.nlm.nih.gov
The circulatory system comprises a tubular network of blood vessels including arterioles,
capillaries, venules, and lymphatic vessels. This circulatory system is essential for the embryonic
development and maintenance of all tissues, which requires the transportation of oxygen, ...
Cited by 2 - Related articles

Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies

F Li… - Science, 2011 - sciencemag.org
CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, is expressed on
antigen-presenting cells (APCs) and is essential for immune activation. Although agonistic CD40
antibodies have been developed for immunotherapy, their clinical efficacy has been ...
Cited by 1

The Multifaceted Role of Cancer Associated Fibroblasts in Tumor Progression

HP Eikesdal… - Tumor-Associated Fibroblasts and their Matrix, 2011 - Springer
R. Kalluri (✉) Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical
Center & Harvard Medical School, 330 Brookline Ave, E/CLS Room #11-090, Center for Life
Sciences, 02115 Boston, MA, USA e-mail: rkalluri@bidmc.harvard.edu Department of ...

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

[HTML] from cshlp.orgKJ Png, M Yoshida, XHF Zhang… - Genes & …, 2011 - genesdev.cshlp.org
Post-transcriptional regulators have emerged as robust effectors of metastasis and display deregulated
expression through unknown mechanisms. Here, we reveal that the human microRNA-335 locus
undergoes genetic deletion and epigenetic promoter hypermethylation in every ...
Cited by 4 - Related articles - All 2 versions

Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation

S Sreeja, TR Santhosh Kumar, BS Lakshmi… - The Journal of …, 2011 - Elsevier
Selective estrogen receptor modulators (SERMs) are estrogen receptor (ER) ligands exhibiting
tissue-specific agonistic or antagonistic biocharacter and are used in the hormonal therapy for
estrogen-dependent breast cancers. Pomegranate fruit has been shown to exert ...

Vasculogenensis, angiogenesis and special features of tumor blood vessels.

S Hiratsuka - Frontiers in bioscience: a journal and virtual library, 2011 - ncbi.nlm.nih.gov
The circulatory system comprises a tubular network of blood vessels including arterioles,
capillaries, venules, and lymphatic vessels. This circulatory system is essential for the embryonic
development and maintenance of all tissues, which requires the transportation of oxygen, ...
Cited by 2 - Related articles

Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies

F Li… - Science, 2011 - sciencemag.org
CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, is expressed on
antigen-presenting cells (APCs) and is essential for immune activation. Although agonistic CD40
antibodies have been developed for immunotherapy, their clinical efficacy has been ...
Cited by 1

The Multifaceted Role of Cancer Associated Fibroblasts in Tumor Progression

HP Eikesdal… - Tumor-Associated Fibroblasts and their Matrix, 2011 - Springer
R. Kalluri (✉) Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical
Center & Harvard Medical School, 330 Brookline Ave, E/CLS Room #11-090, Center for Life
Sciences, 02115 Boston, MA, USA e-mail: rkalluri@bidmc.harvard.edu Department of ...

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

[HTML] from cshlp.orgKJ Png, M Yoshida, XHF Zhang… - Genes & …, 2011 - genesdev.cshlp.org
Post-transcriptional regulators have emerged as robust effectors of metastasis and display deregulated
expression through unknown mechanisms. Here, we reveal that the human microRNA-335 locus
undergoes genetic deletion and epigenetic promoter hypermethylation in every ...
Cited by 4 - Related articles - All 2 versions

Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active …

IF San Francisco, L Werner, MM Regan… - The Journal of …, 2011 - Elsevier
Of the cohort 30% progressed during a median of 2.4 years. Three multivariate analyses were
performed. The first analysis used variables only at diagnosis biopsy and revealed that prostate
specific antigen density greater than 0.08 ng/ml/cc and prostate cancer family history ...
Cited by 3 - Related articles - All 7 versions

The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous …

[PDF] from dominiotemporario.comGL Andriole, D Bostwick, OW Brawley… - The Journal of …, 2011 - Elsevier
Final prostate specific antigen before biopsy and change from month 6 to final prostate specific
antigen performed better for the diagnosis of Gleason score 7–10 tumors in men who received
dutasteride vs placebo as assessed by the area under the ROC curves (0.700 vs 0.650, p ...
Cited by 6 - Related articles - All 7 versions

[HTML] A Multi-Center Study of [− 2] Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/ …

[HTML] from nih.govWJ Catalona, AW Partin, MG Sanda… - The Journal of …, 2011 - ncbi.nlm.nih.gov
Author Affiliations: Department of Urology (Dr. Catalona), Northwestern University Feinberg School
of Medicine Chicago, Illinois; Department of Urology (Drs Partin and Loeb) and Pathology (Drs
Chan and Sokoll), Johns Hopkins University School of Medicine (Drs Partin, Loeb, Chan, ...

… Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific …

[HTML] from urologyaccess.orgWJ Catalona, AW Partin, MG Sanda, JT Wei… - The Journal of …, 2011 - Elsevier
Prostate specific antigen and free prostate specific antigen have limited specificity to detect clinically
significant, curable prostate cancer, leading to unnecessary biopsy, and detection and treatment
of some indolent tumors. Specificity to detect clinically significant prostate cancer may be ...
Cited by 1 - Related articles - All 6 versions

miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation

D Sun, YS Lee, A Malhotra, HK Kim, M Matecic… - Cancer Research, 2011 - AACR
MicroRNAs (miRNA) have been globally profiled in cancers but there tends to be poor agreement
between studies including in the same cancers. In addition, few putative miRNA targets have
been validated. To overcome the lack of reproducibility, we profiled miRNAs by next ...
Cited by 5 - Related articles - All 3 versions

美国ACCDON公司旗下品牌

[HTML] A Multi-Center Study of [− 2] Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/ …